A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 107 participants.

Also called NCT05126238

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 107 participants (enrolled count) (from the registry)
Sponsor
Negovsky Reanimatology Research Institute (from the registry)
Registry
  • NCT NCT05126238
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT05126238. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-20 (actual); primary completion 2025-05-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
Condition
Carotid Artery Diseases
Condition
Carotid Artery Stenosis
Intervention (Drug)
Lithium Carbonate
Intervention (Drug)
Placebo
Lead sponsor
Negovsky Reanimatology Research Institute (class: other government)
Collaborator
Demikhov Municipal Clinical Hospital 68 (class: other government)

Record details

Record id
cardio:ct-nct05126238
Content hash
a01b83f7baccee515baaa85f614630282f5e59608509ea04ee3c6cf891a8ec1c